[Protective effect of adeno-associated virus-mediated neurotrophin-3 on the cochlea of guinea pigs with gentamicin-induced hearing loss].
OBJECTIVE
To study the protective effect of local gene therapy with adeno-associated virus (AAV)-mediated neurotrophin-3 (NT-3) on the function and morphology of the cochlea of guinea pigs with gentamicin-induced hearing loss.


METHODS
Hearing loss was induced with gentamicin (80 mg.kg(-1).day(-1) injected intramuscularly) in 18 pigmented guinea pigs 4 days prior to gene transfer. The guinea pigs were then divided into groups A, B, and C for AAV-mediated NT-3 gene transfer (n=7), AAV infection (n=7) or no particular intervention (n=4), respectively. Mini-Osmotic pump were implanted in either side of the ears in groups A and B, and the guinea pigs were injected with gentamicin (80 mg.kg(-1).day(-1)) intramuscularly since the operation day for 10 consecutive days. In group C, only gentamicin was administrated. Before and 14 days after gentamicin administration, auditory brainstem response audiometry (ABR) and distort-product otoacoustic emissions (DPOAE) were recorded, and the animals sacrificed to observe the morphological changes of the cochlear microscopically.


RESULTS
Compared with groups B and C, the animals in group A showed better auditory ability (ABR and DPOAE) and significantly higher surviving rate of the outer hair cells (P<0.05).


CONCLUSIONS
AAV-mediated NT-3 gene transfer may protect and repair the cochlear hair cells and auditory function damaged by aminoglycoside ototoxicity in guinea pigs, and aseptic procedure is of vital importance in cochlear local gene therapy.
Yao
Xiao-bao
XB
Department of Otolaryngology, First Affiliated Hospital of School of Medicine, Xi'an Jiaotong University, Xi'an 710061, China. yaoxiaobao@sohu.com
Li
Sheng-li
SL
Zhu
Hong-liang
HL
Wang
Xiao-xia
XX
Liu
Hui
H
Yan
Li-ying
LY
D000818:Animals; D003051:Cochlea / Q000503:physiopathology*; D000229:Dependovirus / Q000235:genetics / Q000378:metabolism; D015316:Genetic Therapy; D005839:Gentamicins / Q000009:adverse effects; D006168:Guinea Pigs; D034381:Hearing Loss / Q000139:chemically induced / Q000628:therapy*; D020933:Neurotrophin 3 / Q000627:therapeutic use*
D005839:Gentamicins; D020933:Neurotrophin 3